These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25139337)

  • 1. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2014 Nov; 66(11):663-9. PubMed ID: 25139337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
    Haralambieva IH; Ovsyannikova IG; Umlauf BJ; Vierkant RA; Shane Pankratz V; Jacobson RM; Poland GA
    Vaccine; 2011 Nov; 29(48):8988-97. PubMed ID: 21939710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
    Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
    Haralambieva IH; Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Hum Immunol; 2010 Apr; 71(4):383-91. PubMed ID: 20079393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
    White SJ; Haralambieva IH; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
    Hum Immunol; 2012 Jun; 73(6):636-40. PubMed ID: 22504412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
    Dhiman N; Haralambieva IH; Kennedy RB; Vierkant RA; O'Byrne MM; Ovsyannikova IG; Jacobson RM; Poland GA
    Immunogenetics; 2010 Apr; 62(4):197-210. PubMed ID: 20217072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine.
    Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
    Pharmacogenet Genomics; 2012 Jan; 22(1):20-31. PubMed ID: 22082653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.
    Ovsyannikova IG; Dhiman N; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
    Hum Genet; 2010 Feb; 127(2):207-21. PubMed ID: 19902255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.
    Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
    Hum Hered; 2011; 72(3):206-23. PubMed ID: 22086389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
    Umlauf BJ; Haralambieva IH; Ovsyannikova IG; Kennedy RB; Pankratz VS; Jacobson RM; Poland GA
    Viral Immunol; 2012 Feb; 25(1):29-36. PubMed ID: 22239234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.
    Ovsyannikova IG; Haralambieva IH; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Hum Genet; 2011 Oct; 130(4):547-61. PubMed ID: 21424379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
    Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
    Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.
    Dhiman N; Ovsyannikova IG; Vierkant RA; Ryan JE; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2008 Mar; 26(14):1731-6. PubMed ID: 18325643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.